Drug shows promise in preventing seizures after stroke, early trial finds

A new antiepileptic medication reduced seizure risk in stroke patients prone to post-stroke epilepsy, according to a phase 2 trial published in The Lancet Neurology. If confirmed in larger studies, the finding could change how hospitals treat high-risk stroke survivors and reduce disability and healthcare costs from preventable seizures.

Originaltitel: Safety and efficacy of eslicarbazepine acetate for seizure prevention in patients with stroke at high risk of developing post-stroke epilepsy: a proof-of-concept, phase 2a, randomised, double-blind, placebo-controlled antiepileptogenesis trial